142 related articles for article (PubMed ID: 23111799)
1. [Contrast-enhanced ultrasound].
Jaspers N; Pfister R; Kinkel H; Michels G
Dtsch Med Wochenschr; 2012 Nov; 137(45):2336-9. PubMed ID: 23111799
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20 mm) and subcentimetric (≤ 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
[TBL] [Abstract][Full Text] [Related]
5. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.
Piscaglia F; Nolsøe C; Dietrich CF; Cosgrove DO; Gilja OH; Bachmann Nielsen M; Albrecht T; Barozzi L; Bertolotto M; Catalano O; Claudon M; Clevert DA; Correas JM; D'Onofrio M; Drudi FM; Eyding J; Giovannini M; Hocke M; Ignee A; Jung EM; Klauser AS; Lassau N; Leen E; Mathis G; Saftoiu A; Seidel G; Sidhu PS; ter Haar G; Timmerman D; Weskott HP
Ultraschall Med; 2012 Feb; 33(1):33-59. PubMed ID: 21874631
[No Abstract] [Full Text] [Related]
6. Ultrasound imaging with SonoVue: low mechanical index real-time imaging.
Bauer A; Solbiati L; Weissman N
Acad Radiol; 2002 Aug; 9 Suppl 2():S282-4. PubMed ID: 12188249
[No Abstract] [Full Text] [Related]
7. An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion.
Dietrich CF; Averkiou MA; Correas JM; Lassau N; Leen E; Piscaglia F
Ultraschall Med; 2012 Aug; 33(4):344-51. PubMed ID: 22843433
[TBL] [Abstract][Full Text] [Related]
8. Intracavitary applications of ultrasound contrast agents in hepatogastroenterology.
Sparchez Z; Radu P; Sparchez M; Vasile T; Anton O; Tantau M
J Gastrointestin Liver Dis; 2013 Sep; 22(3):349-53. PubMed ID: 24078996
[TBL] [Abstract][Full Text] [Related]
9. EFSUMB guidelines 2011: comments and illustrations.
Dietrich CF; Cui XW; Schreiber-Dietrich DG; Ignee A
Ultraschall Med; 2012 Jul; 33 Suppl 1():S11-21. PubMed ID: 22723024
[TBL] [Abstract][Full Text] [Related]
10. The contribution of contrast enhanced ultrasound for the characterization of benign liver lesions in clinical practice - a monocentric experience.
Martie A; Bota S; Sporea I; Sirli R; Popescu A; Danila M
Med Ultrason; 2012 Dec; 14(4):283-7. PubMed ID: 23243641
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions.
Beaton C; Cochlin D; Kumar N
Eur J Surg Oncol; 2010 Jan; 36(1):43-6. PubMed ID: 19709846
[TBL] [Abstract][Full Text] [Related]
12. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous delayed enhancement of the liver after administration of ultrasound contrast agents: are we sure that it is a harmless phenomenon?
Tana C; Iannetti G; Mezzetti A; Schiavone C
Ultrasound Med Biol; 2013 Nov; 39(11):2214. PubMed ID: 23932275
[No Abstract] [Full Text] [Related]
14. Ultrasound microbubble contrast and current clinical applications.
Dindyal S; Kyriakides C
Recent Pat Cardiovasc Drug Discov; 2011 Jan; 6(1):27-41. PubMed ID: 21222650
[TBL] [Abstract][Full Text] [Related]
15. Hypoechoic focal liver lesions: characterization with contrast enhanced ultrasonography.
D'Onofrio M; Rozzanigo U; Masinielli BM; Caffarri S; Zogno A; Malagò R; Procacci C
J Clin Ultrasound; 2005 May; 33(4):164-72. PubMed ID: 15856516
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous staining in the liver parenchyma after the injection of perflubutane microbubble contrast agent.
Shimada T; Maruyama H; Sekimoto T; Kamezaki H; Takahashi M; Yokosuka O
Ultrasound Med Biol; 2012 Aug; 38(8):1317-23. PubMed ID: 22698509
[TBL] [Abstract][Full Text] [Related]
17. Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.
Zhou X; Liu JB; Luo Y; Yan F; Peng Y; Lin L; Zhuang H
Radiology; 2010 Aug; 256(2):648-55. PubMed ID: 20656845
[TBL] [Abstract][Full Text] [Related]
18. "Hot topics" in Contrast-Enhanced Ultrasound (CEUS)--introduction.
Mostbeck G
Ultraschall Med; 2012 Jul; 33 Suppl 1():S1-2. PubMed ID: 22723023
[No Abstract] [Full Text] [Related]
19. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
[TBL] [Abstract][Full Text] [Related]
20. How useful is contrast enhanced ultrasonography for the characterization of focal liver lesions?
Sporea I; Sirli R; Martie A; Popescu A; Danila M
J Gastrointestin Liver Dis; 2010 Dec; 19(4):393-8. PubMed ID: 21188330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
